Goh BC - Search Results

1

Targeting transcription factor STAT3 for cancer prevention and therapy.

Chai EZ, Shanmugam MK, Arfuso F, Dharmarajan A, Wang C, Kumar AP, Samy RP, Lim LH, Wang L, Goh BC, Ahn KS, Hui KM, Sethi G. Chai EZ, et al. Among authors: goh bc. Pharmacol Ther. 2016 Jun;162:86-97. doi: 10.1016/j.pharmthera.2015.10.004. Epub 2016 Feb 12. Pharmacol Ther. 2016. PMID: 26478441 Review.

2

Phenotyping CYP3A using midazolam in cancer and noncancer Asian patients.

Lee HS, Goh BC, Fan L, Khoo YM, Wang L, Lim R, Ong AB, Chua C. Lee HS, et al. Among authors: goh bc. Br J Clin Pharmacol. 2003 Mar;55(3):270-7. doi: 10.1046/j.1365-2125.2003.01767.x. Br J Clin Pharmacol. 2003. PMID: 12630977 Free PMC article.

3

An expedient assay for determination of gemcitabine and its metabolite in human plasma using isocratic ion-pair reversed-phase high-performance liquid chromatography.

Wang LZ, Goh BC, Lee HS, Noordhuis P, Peters GJ. Wang LZ, et al. Among authors: goh bc. Ther Drug Monit. 2003 Oct;25(5):552-7. doi: 10.1097/00007691-200310000-00003. Ther Drug Monit. 2003. PMID: 14508377

4

Sensitive high-performance liquid chromatography/mass spectrometry method for determination of steviol in rat plasma.

Wang LZ, Goh BC, Fan L, Lee HS. Wang LZ, et al. Among authors: goh bc. Rapid Commun Mass Spectrom. 2004;18(1):83-6. doi: 10.1002/rcm.1285. Rapid Commun Mass Spectrom. 2004. PMID: 14689563

5

Ketoconazole renders poor CYP3A phenotype status with midazolam as probe drug.

Tham LS, Lee HS, Wang L, Yong WP, Fan L, Ong AB, Sukri N, Soo R, Lee SC, Goh BC. Tham LS, et al. Among authors: goh bc. Ther Drug Monit. 2006 Apr;28(2):255-61. doi: 10.1097/01.ftd.0000194497.55269.d9. Ther Drug Monit. 2006. PMID: 16628140 Clinical Trial.

6

Effects of high dose of simvastatin on levels of dopamine and its reuptake in prefrontal cortex and striatum among SD rats.

Wang Q, Tang XN, Wang L, Yenari MA, Ying W, Goh BC, Lee HS, Wilder-Smith EP, Wong PT. Wang Q, et al. Among authors: goh bc. Neurosci Lett. 2006 Nov 20;408(3):189-93. doi: 10.1016/j.neulet.2006.09.009. Epub 2006 Sep 22. Neurosci Lett. 2006. PMID: 16996211

7

A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9.

Tham LS, Goh BC, Nafziger A, Guo JY, Wang LZ, Soong R, Lee SC. Tham LS, et al. Among authors: goh bc. Clin Pharmacol Ther. 2006 Oct;80(4):346-55. doi: 10.1016/j.clpt.2006.06.009. Clin Pharmacol Ther. 2006. PMID: 17015052

8

A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers.

Yong WP, Wang LZ, Tham LS, Wong CI, Lee SC, Soo R, Sukri N, Lee HS, Goh BC. Yong WP, et al. Among authors: goh bc. Cancer Chemother Pharmacol. 2008 Jul;62(2):243-51. doi: 10.1007/s00280-007-0598-1. Epub 2007 Oct 2. Cancer Chemother Pharmacol. 2008. PMID: 17909805 Clinical Trial.

9

Lack of association of single-nucleotide polymorphisms in pregnane X receptor, hepatic nuclear factor 4alpha, and constitutive androstane receptor with docetaxel pharmacokinetics.

Tham LS, Holford NH, Hor SY, Tan T, Wang L, Lim RC, Lee HS, Lee SC, Goh BC. Tham LS, et al. Among authors: goh bc. Clin Cancer Res. 2007 Dec 1;13(23):7126-32. doi: 10.1158/1078-0432.CCR-07-1276. Clin Cancer Res. 2007. PMID: 18056193 Clinical Trial.

10

Does saturable formation of gemcitabine triphosphate occur in patients?

Tham LS, Wang LZ, Soo RA, Lee HS, Lee SC, Goh BC, Holford NH. Tham LS, et al. Among authors: goh bc. Cancer Chemother Pharmacol. 2008 Dec;63(1):55-64. doi: 10.1007/s00280-008-0707-9. Epub 2008 Feb 28. Cancer Chemother Pharmacol. 2008. PMID: 18305939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

334 results

Search Page